LAKE
FOREST, Calif., June 14,
2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL),
the global leader in dental lasers, today announced that
President and Chief Executive Officer, John
Beaver and Chief Financial Officer, Jennifer Bright, have been invited to
participate in the 2023 Virtual Healthcare Conference, presented by
Maxim Group LLC and hosted by M-Vest, on June 20th to 22nd.
BIOLASE will participate in a fireside chat with
Maxim's senior research analyst Anthony Vendetti, on
Tuesday, June 20th at 10:30 am
ET. BIOLASE management will be available for one-on-one meetings
from June 20, 2023 through
June 22, 2023. To receive additional
information, request an invitation, or schedule a one-on-one
meeting, please email angie.wright@issuerdirect.com.
The exponential growth in knowledge and expertise in science and
medicine continues to drive opportunities in the healthcare space.
These include multiple therapeutic categories and emerging
technologies, which our presenting companies at this year's Maxim
Healthcare Conference are focused on, and for many, that includes
key data-driven events in 2023. Maxim Senior Analysts will host a
wide range of biotechnology and medical device companies in a
series of presentations and interactive discussions with CEOs and
key management. We will also be hosting several topical industry
panels that promise to be timely and engaging.
This conference will be live on M-Vest. To attend, just sign up
to become an M-Vest member.
Click Here to Reserve your seat
About BIOLASE
BIOLASE is a medical device company that develops, manufactures,
markets, and sells laser systems in dentistry and medicine.
BIOLASE's products advance the practice of dentistry and medicine
for patients and healthcare professionals. BIOLASE's proprietary
laser products incorporate approximately 266 patented and 25
patent-pending technologies designed to provide biologically and
clinically superior performance with less pain and faster recovery
times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are dental
laser systems that perform a broad range of dental procedures,
including cosmetic and complex surgical applications. From 1998
through December 31, 2022, BIOLASE
has sold over 45,500 laser systems in over 80 countries around the
world. Laser products under development address BIOLASE's core
dental market and other adjacent medical and consumer
applications.
For updates and information on Waterlase iPlus®, Waterlase
Express™, and laser dentistry, find BIOLASE online at
www.biolase.com, Facebook at www.facebook.com/biolase, Twitter
at www.twitter.com/biolaseinc, Instagram at
www.instagram.com/waterlase_laserdentistry, and LinkedIn at
www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered
trademarks of BIOLASE, Inc.
For further information, please contact:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-to-participate-in-maxim-groups-2023-virtual-healthcare-conference-hosted-by-m-vest-on-june-20th--22nd-301851203.html
SOURCE BIOLASE, Inc.